Milestone Scientific (NYSE:MLSS) Now Covered by StockNews.com

StockNews.com began coverage on shares of Milestone Scientific (NYSE:MLSS) in a research note issued to investors on Wednesday. The brokerage set a “hold” rating on the stock.

Separately, Benchmark restated a “speculative buy” rating and issued a $1.25 price objective on shares of Milestone Scientific in a research report on Wednesday, November 20th.

Milestone Scientific Stock Performance

MLSS opened at $0.88 on Wednesday. The business’s fifty day moving average is $0.83 and its two-hundred day moving average is $0.85. The company has a market cap of $68.54 million, a price-to-earnings ratio of -12.57 and a beta of 1.10. Milestone Scientific has a one year low of $0.52 and a one year high of $1.10.

Insiders Place Their Bets

In other Milestone Scientific news, Director Leonard Osser sold 107,984 shares of the company’s stock in a transaction dated Tuesday, October 22nd. The stock was sold at an average price of $0.93, for a total transaction of $100,425.12. Following the completion of the sale, the director now directly owns 4,606,882 shares in the company, valued at $4,284,400.26. This represents a 2.29 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. Insiders sold 109,193 shares of company stock worth $101,634 over the last three months. 24.75% of the stock is owned by insiders.

Institutional Investors Weigh In On Milestone Scientific

Large investors have recently modified their holdings of the stock. Geode Capital Management LLC grew its stake in shares of Milestone Scientific by 6.4% in the third quarter. Geode Capital Management LLC now owns 527,005 shares of the company’s stock valued at $480,000 after buying an additional 31,572 shares in the last quarter. World Investment Advisors LLC acquired a new stake in shares of Milestone Scientific in the third quarter valued at about $91,000. Finally, Y Intercept Hong Kong Ltd acquired a new stake in shares of Milestone Scientific in the third quarter valued at about $48,000. Institutional investors and hedge funds own 5.79% of the company’s stock.

About Milestone Scientific

Milestone Scientific Inc, a biomedical technology research and development company, patents, designs, develops, and commercializes diagnostic and therapeutic injection technologies, and devices for medical, dental, and cosmetic use in the United States, China, and internationally. The company operates through Dental and Medical segments.